These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9331631)

  • 21. Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates.
    Newton D; Norrby-Teglund A; McGeer A; Low DE; Schlievert PM; Kotb M
    Adv Exp Med Biol; 1997; 418():525-9. PubMed ID: 9331707
    [No Abstract]   [Full Text] [Related]  

  • 22. Streptococcal toxic shock syndrome after breast reconstruction.
    Agerson AN; Wilkins EG
    Ann Plast Surg; 2005 May; 54(5):553-6. PubMed ID: 15838219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Streptococcal toxic shock syndrome from a puncture wound to the foot.
    Miller JH; Nath RL; Stoughton J; Carpenter BB; Mostone EJ
    J Foot Ankle Surg; 1996; 35(6):578-84. PubMed ID: 8986898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.
    Lamothe F; D'Amico P; Ghosn P; Tremblay C; Braidy J; Patenaude JV
    Clin Infect Dis; 1995 Dec; 21(6):1469-70. PubMed ID: 8749635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infections due to group A streptococcus: new concepts and potential treatment strategies.
    Norrby SR; Norrby-Teglund A
    Ann Acad Med Singap; 1997 Sep; 26(5):691-3. PubMed ID: 9494680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group A streptococcal toxic shock syndrome from a traumatic myositis.
    Lo SS; Mittal A; Stewart I
    N Z Med J; 2010 Jun; 123(1317):65-7. PubMed ID: 20657633
    [No Abstract]   [Full Text] [Related]  

  • 27. [Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empyema].
    Bosland A; Arlaud K; Rousset-Rouvière C; Fouilloux V; Paut O; Dubus JC; Bosdure E
    Arch Pediatr; 2011 Dec; 18(12):1310-4. PubMed ID: 22041597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
    Stevens DL
    Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
    Baxter M; Morgan M
    Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dilemmas in the treatment of invasive Streptococcus pyogenes infections.
    Stevens DL
    Clin Infect Dis; 2003 Aug; 37(3):341-3. PubMed ID: 12884157
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primary peritonitis combined with streptococcal toxic shock syndrome following an upper respiratory tract infection caused by Streptococcus pyogenes].
    Van Den Bossche MJ; Devriendt D; Weyne L; Van Ranst M
    Ned Tijdschr Geneeskd; 2008 Apr; 152(15):891-4. PubMed ID: 18512531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptolysin O modulates cytokine synthesis in human peripheral blood mononuclear cells.
    Stevens DL; Bryant AE
    Adv Exp Med Biol; 1997; 418():925-7. PubMed ID: 9331801
    [No Abstract]   [Full Text] [Related]  

  • 33. Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome.
    Assimacopoulos AP; Stoehr JA; Schlievert PM
    Adv Exp Med Biol; 1997; 418():109-14. PubMed ID: 9331611
    [No Abstract]   [Full Text] [Related]  

  • 34. Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes. Structure and function.
    Musser JM
    Prep Biochem Biotechnol; 1997; 27(2-3):143-72. PubMed ID: 9292924
    [No Abstract]   [Full Text] [Related]  

  • 35. Group A Streptococcus invasive infections: a review.
    Weiss KA; Laverdière M
    Can J Surg; 1997 Feb; 40(1):18-25. PubMed ID: 9030079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.
    Talkington DF; Schwartz B; Black CM; Todd JK; Elliott J; Breiman RF; Facklam RR
    Infect Immun; 1993 Aug; 61(8):3369-74. PubMed ID: 8335368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens.
    Fenwick P; Ryan C; Sriskandan S; Cohen J
    Crit Care Med; 2003 Jan; 31(1):171-8. PubMed ID: 12545012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature.
    Tilanus AM; de Geus HR; Rijnders BJ; Dwarkasing RS; van der Hoven B; Bakker J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e208-12. PubMed ID: 19914115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital streptococcal toxic shock syndrome with absence of antibodies against streptococcal pyrogenic exotoxins.
    Mahieu LM; Holm SE; Goossens HJ; Van Acker KJ
    J Pediatr; 1995 Dec; 127(6):987-9. PubMed ID: 8523204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
    Schlievert PM
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S107-10. PubMed ID: 11586276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.